Orchestra Biomed Holdings Stock Price on February 20, 2024
| OBIO Stock | 5.26 0.08 1.50% |
Below is the normalized historical share price chart for Orchestra BioMed Holdings extending back to August 04, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Orchestra BioMed stands at 5.26, as last reported on the 14th of December 2024, with the highest price reaching 5.38 and the lowest price hitting 5.05 during the day.
If you're considering investing in Orchestra Stock, it is important to understand the factors that can impact its price. Orchestra BioMed appears to be slightly risky, given 3 months investment horizon. Orchestra BioMed Holdings maintains Sharpe Ratio (i.e., Efficiency) of 0.0454, which implies the firm had a 0.0454% return per unit of risk over the last 3 months. We have found twenty-two technical indicators for Orchestra BioMed Holdings, which you can use to evaluate the volatility of the company. Please evaluate Orchestra BioMed's Variance of 26.01, coefficient of variation of (39,678), and Risk Adjusted Performance of 0.0068 to confirm if our risk estimates are consistent with your expectations.
At this time, Orchestra BioMed's Total Stockholder Equity is very stable compared to the past year. As of the 14th of December 2024, Capital Stock is likely to grow to 4,200, while Common Stock Shares Outstanding is likely to drop about 24.5 M. . At this time, Orchestra BioMed's Price To Sales Ratio is very stable compared to the past year. As of the 14th of December 2024, Price Book Value Ratio is likely to grow to 4.68, while Price Earnings Ratio is likely to drop (6.48). Orchestra Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 4th of August 2020 | 200 Day MA 5.9645 | 50 Day MA 5.5387 | Beta 0.409 |
Orchestra |
Sharpe Ratio = 0.0454
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | OBIO | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.79 actual daily | 42 58% of assets are more volatile |
Expected Return
| 0.22 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 3 97% of assets perform better |
Based on monthly moving average Orchestra BioMed is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Orchestra BioMed by adding it to a well-diversified portfolio.
Price Book 4.3701 | Enterprise Value Ebitda (1.81) | Price Sales 76.8312 | Shares Float 17.6 M | Wall Street Target Price 15.6 |
Related Headline
Asbury Automotive Headline on 20th of February 2024
Acquisition by Nathan Briesemeister of 346 shares of Asbury ... by Nathan Briesemeister
Filed transaction by Asbury Automotive Group Officer: Vp, Controller & Cao. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Orchestra BioMed Valuation on February 20, 2024
It is possible to determine the worth of Orchestra BioMed on a given historical date. On February 20, 2024 Orchestra was worth 6.31 at the beginning of the trading date compared to the closed value of 5.9. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Orchestra BioMed stock. Still, in general, we apply an absolute valuation method to find Orchestra BioMed's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Orchestra BioMed where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Orchestra BioMed's related companies.
| Open | High | Low | Close | Volume | |
| 6.91 | 6.91 | 6.39 | 6.39 | 28,122 | |
02/20/2024 | 6.31 | 6.35 | 5.90 | 5.90 | 81,579 |
| 5.86 | 6.06 | 5.67 | 5.78 | 34,271 |
| Backtest Orchestra BioMed | | | Orchestra BioMed History | | | Orchestra BioMed Valuation | Previous | Next |
Orchestra BioMed Trading Date Momentum on February 20, 2024
| On February 21 2024 Orchestra BioMed Holdings was traded for 5.78 at the closing time. The top price for the day was 6.06 and the lowest listed price was 5.67 . The trading volume for the day was 34.3 K. The trading history from February 21, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 2.03% . The trading delta at closing time against the current closing price is 10.85% . |
Orchestra BioMed Holdings Fundamentals Correlations and Trends
By evaluating Orchestra BioMed's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Orchestra BioMed's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Orchestra financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Orchestra BioMed Stock history
Orchestra BioMed investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Orchestra is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Orchestra BioMed Holdings will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Orchestra BioMed stock prices may prove useful in developing a viable investing in Orchestra BioMed
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 33.2 M | 24.5 M | |
| Net Loss | -20.7 M | -21.7 M |
Orchestra BioMed Stock Technical Analysis
Orchestra BioMed technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Orchestra BioMed Period Price Range
Low | December 14, 2024
| High |
0.00 | 0.00 |
Orchestra BioMed Holdings cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Orchestra BioMed December 14, 2024 Market Strength
Market strength indicators help investors to evaluate how Orchestra BioMed stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Orchestra BioMed shares will generate the highest return on investment. By undertsting and applying Orchestra BioMed stock market strength indicators, traders can identify Orchestra BioMed Holdings entry and exit signals to maximize returns
Orchestra BioMed Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Orchestra BioMed's price direction in advance. Along with the technical and fundamental analysis of Orchestra Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Orchestra to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0068 | |||
| Jensen Alpha | (0.18) | |||
| Total Risk Alpha | (0.66) | |||
| Treynor Ratio | (0.01) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Orchestra BioMed Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Orchestra BioMed. If investors know Orchestra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Orchestra BioMed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.60) | Revenue Per Share 0.073 | Quarterly Revenue Growth 1.356 | Return On Assets (0.39) | Return On Equity (0.92) |
The market value of Orchestra BioMed Holdings is measured differently than its book value, which is the value of Orchestra that is recorded on the company's balance sheet. Investors also form their own opinion of Orchestra BioMed's value that differs from its market value or its book value, called intrinsic value, which is Orchestra BioMed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Orchestra BioMed's market value can be influenced by many factors that don't directly affect Orchestra BioMed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Orchestra BioMed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Orchestra BioMed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Orchestra BioMed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.